Why It Matters Additional randomized, controlled trials that follow people over time are needed to confirm these findings, but these results are promising, since people with diabetes are at increased risk for developing epilepsy later in life, said study author Edy Kornelius, MD, PhD, of Chung Shan Medical University in Taichung, Taiwan
Integrated transcriptomic and epigenetic study of PCOS: impact of map3k1 and map1lc3a promoter methylation on autophagy
Shes quick to point out that the treatment didnt erase her commitment to training but gave her body the push it needed to respond
Heres a look at how they differ
Nooms individualized program, leveraging SmartDose, breaks free of the rigid schedule